|
TEAD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14060000000471E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.565950E-04 |
| Normal-vs-Stage2 |
2.05299999999076E-05 |
| Normal-vs-Stage3 |
1.90439999991909E-07 |
| Normal-vs-Stage4 |
2.77419999972217E-07 |
| Stage1-vs-Stage2 |
5.088100E-02 |
| Stage1-vs-Stage3 |
8.485000E-03 |
| Stage1-vs-Stage4 |
1.254310E-02 |
| Stage2-vs-Stage3 |
9.687600E-01 |
| Stage2-vs-Stage4 |
8.901000E-01 |
| Stage3-vs-Stage4 |
8.230800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.3179999997236E-07 |
| Normal-vs-AfricanAmerican |
6.918400E-02 |
| Normal-vs-Asian |
6.367600E-01 |
| Caucasian-vs-AfricanAmerican |
1.147970E-02 |
| Caucasian-vs-Asian |
2.575500E-03 |
| AfricanAmerican-vs-Asian |
1.849380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.02000000001823E-06 |
| Normal-vs-Female |
7.72910000002014E-07 |
| Male-vs-Female |
6.074200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.042500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.06319999995763E-06 |
| Normal-vs-Age(61-80Yrs) |
4.70010000030996E-07 |
| Normal-vs-Age(81-100Yrs) |
5.79820000012887E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.577000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.048050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.476330E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.071200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.808490E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.517970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.632400E-01 |
| Normal-vs-Grade 2 |
3.68080000000548E-05 |
| Normal-vs-Grade 3 |
2.80599998792042E-09 |
| Normal-vs-Grade 4 |
9.64810000000371E-05 |
| Grade 1-vs-Grade 2 |
3.401700E-02 |
| Grade 1-vs-Grade 3 |
5.54139999999759E-05 |
| Grade 1-vs-Grade 4 |
1.998480E-02 |
| Grade 2-vs-Grade 3 |
2.15789999999938E-05 |
| Grade 2-vs-Grade 4 |
2.262800E-01 |
| Grade 3-vs-Grade 4 |
1.355160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.73820002414527E-09 |
| Normal-vs-ccB subtype |
2.162000E-04 |
| ccA subtype-vs-ccB subtype |
2.162700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.90279999990173E-07 |
| Normal-vs-N1 |
5.625500E-04 |
| N0-vs-N1 |
1.976170E-01 |
|
|
